Creative Proteomics, a leading global provider of proteomics services, is proud to announce the launch of its innovative Absolute Quantification (AQUA) service, offering scientists a highly accurate solution for protein quantification analysis. This groundbreaking service will play a crucial role in life science research, drug development, and clinical diagnostics.
Absolute Quantification (AQUA) is an advanced mass spectrometry-based quantitative method that enables the precise measurement of the absolute abundance of specific proteins in complex biological samples. Compared to traditional relative quantification methods, the AQUA technology achieves higher accuracy and reliability by utilizing known amounts of isotopically labeled peptide standards as internal standards.
Creative Proteomics’ AQUA service utilizes state-of-the-art mass spectrometry instruments and specialized analysis software to ensure customers receive high-quality quantitative data, providing robust support for their research.
“Protein quantification is a critical step in many life science studies,” says the senior scientist of Creative Proteomics. “We are proud to introduce this innovative AQUA service, offering scientists a more accurate and reliable solution for quantitative analysis. This service is not only applicable to basic research but also provides valuable support for professionals in drug development and clinical diagnostics.”
Key Advantages of Creative Proteomics’ AQUA service include:
By introducing the Absolute Quantification (AQUA) service, Creative Proteomics reinforces its position as a leader in the field of proteomics and demonstrates its ongoing commitment to addressing customer needs and driving innovation. As a premier provider of proteomics solutions worldwide, Creative Proteomics is dedicated to offering cutting-edge technologies and superior services, advancing life science research and innovation.
About Creative Proteomics
Creative Proteomics, an experienced proteomics, metabolomics, and bioinformatics services supplier, is well equipped with advanced technologies in order to meet the increasing needs of scientists in proteomics and metabolomics-related research.